Key Points:
·PMI Korea has released a new e-cigarette product called "Teria Twilight Pearl."
·The new product uses a unique capsule design to switch from a strong tobacco flavor to a fresh taste.
·"Teria Twilight Pearl" caters to adult smokers' desires for diverse flavors.
·The new product will be available nationwide starting on the 26th, with prices the same as existing products.
【2Firsts News Flash】Philip Morris International (PMI) Korea announced the launch of the new capsule-style product "Teria Twilight Pearl" for the HNB e-cigarette devices IQOS Iluma and IQOS Iluma i series.
According to the introduction, Teria Twilight Pearl is a innovative product that offers the rich flavor of raw tobacco as the base, with built-in flavor capsules that users can press to switch to a fresh fruity flavor. Users can easily switch between the two flavors.
This product is designed to meet the needs of adult consumers who enjoy traditional tobacco flavors but also seek unique taste experiences.
"Teria Twilight Pearl" will be available for purchase starting from June 26th at all national IQOS official stores and convenience store channels, with a suggested retail price of 4,800 Korean won, which is consistent with the existing Teria series products.
With the introduction of the product, the Teria capsule product line has now expanded to five, including: Teria Twilight Pearl, Teria Sterling Pearl, Teria Arbor Pearl, Teria Sun Pearl, Teria Oasis Pearl.
South Korea's PMI has stated that the company will continue to introduce a variety of flavors of products in order to constantly expand consumer choice.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.
